HBK Investments’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-15,782
Closed -$1.71M 1221
2018
Q4
$1.71M Buy
15,782
+8,682
+122% +$1.16M 0.02% 522
2018
Q3
$1.06M Buy
+7,100
New +$1.08M 0.01% 701
2018
Q2
Sell
-16,296
Closed -$2.27M 1096
2018
Q1
$2.27M Buy
+16,296
New +$2.39M 0.02% 425
2017
Q2
Sell
-1,630
Closed -$201K 971
2017
Q1
$201K Buy
+1,630
New +$193K ﹤0.01% 636
2016
Q3
Sell
-14,818
Closed -$1.66M 923
2016
Q2
$1.66M Buy
14,818
+10,894
+278% +$1.17M 0.01% 462
2016
Q1
$395K Buy
+3,924
New +$376K ﹤0.01% 775
2015
Q2
Sell
-66,220
Closed -$7.17M 1017
2015
Q1
$7.17M Buy
+66,220
New +$6.81M 0.07% 179

Other funds holding LH

HBK Investments's LH Position: Q1 2019 in Review

HBK Investments sold out of Labcorp (LH) in Q1 2019, closing a stake of 15,782 shares — an estimated $1.71M sold.

HBK Investments first reported a position in LH in Q1 2015 and held it in 7 quarters. The position peaked at $7.17M in Q1 2015. 744 funds tracked by Wall St. Rank hold LH as of Q1 2019.

  • HBK Investments reported no remaining Labcorp position as of Q1 2019 after selling out during the quarter.
  • HBK Investments sold 15,782 Labcorp shares in Q1 2019, an estimated $1.71M.
  • HBK Investments first reported a position in Labcorp in Q1 2015 and held it in 7 quarters.
  • HBK Investments's Labcorp position peaked at $7.17M in Q1 2015.
  • 744 funds tracked by Wall St. Rank held Labcorp as of Q1 2019.

Based on HBK Investments's 13F filing for Q1 2019, filed 15 May 2019.